Search Within

Mark Kris

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (13)
  3. Book Section (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (31)
  2. Center for Molecular Imaging and Biotechnology (31)
  3. Department of Medicine (31)
  4. GSK Faculty (31)
  5. Solid Tumor Oncology Division (31)
  6. Thoracic Oncology (31)

More Groups

People
  1. Charles Rudin (23)
  2. Gregory Riely (9)
  3. Alexander Drilon (8)
  4. Andrew Plodkowski (7)
  5. Camelia Sima (7)
  6. Lee Krug (7)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (3)
  6. 2017 (3)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Journal of Thoracic Oncology (3)
  3. Cancer Discovery (2)
  4. Cancer Research (2)
  5. Cell (2)
  6. Lung Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (5)
  3. Elsevier Inc. (5)
  4. Cell Press (3)
  5. Elsevier Ireland Ltd. (2)
  6. American Medical Association (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting S100A9–ALDH1A1–retinoic acid signaling to suppress brain relapse in EGFR-mutant lung cancer
    Journal Article

    Biswas, A. K.; Han, S.; Tai, Y.; Ma, W.; Coker, C.; Quinn, S. A.; Shakri, A. R.; Zhong, T. J.; Scholze, H.; Lagos, G. G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
    Journal Article

    Tanaka, K.; Yu, H. A.; Yang, S.; Han, S.; Selcuklu, S. D.; Kim, K.; Ramani, S.; Ganesan, Y. T.; Moyer, A.; Sinha, S.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Egger, J. V.; Rizvi, H.; Richards, A. L.; Beras, A.; Baine, M. K.; Hsieh, M. S.; Chang, J. C.; Rekhtman, N.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Real-world experience and molecular features of response to immune checkpoint blockade in patients with recurrent small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Ginsberg, M. S.; Kris, M. G.; Beras, A.; Rekhtman, N.; Poirier, J. T.; Hellmann, M. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: A retrospective international multicentre study
    Journal Article

    Lai, W. V.; Lebas, L.; Barnes, T. A.; Milia, J.; Ni, A.; Gautschi, O.; Peters, S.; Ferrara, R.; Plodkowski, A. J.; Kavanagh, J.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Waqar, S. N.; Krug, L. M.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K. M.; Cardnell, R. J.; Fujimoto, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of re-treating with immunotherapy after immune-related adverse events in patients with NSCLC
    Journal Article

    Santini, F. C.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Lacouture, M. E.; Gambarin-Gelwan, M.; Wilkins, O.; Panora, E.; Halpenny, D. F.; Long, N. M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic HER2-mutant lung cancers: An international multicenter study
    Meeting Abstract

    Lai, W. C. V.; Lebas, L.; Milia, J.; Barnes, T. A.; Gautschi, O.; Peters, S.; Ferrara, R.; Ni, A.; Sabari, J. K.; Clarke, S. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save